Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Duggan

Showing results (171-180 of 316) with videos related to

Pageof 32
Sort By:
Muscle & Nerve|May 19, 1998
Homozygous alpha-sarcoglycan mutation in two siblings: one asymptomatic and one steroid-responsive mild limb-girdle muscular dystrophy patientC Angelini, M Fanin, E Menegazzo, et al.
Neurology|January 28, 1999
The clinical spectrum of sarcoglycanopathiesC Angelini, M Fanin, M P Freda, et al.
Pathology Annual|January 1, 1991
Non-Hodgkin's lymphomas of mantle zone originD D Weisenburger, M J Duggan, D A Perry, et al.
Clinics in Sports Medicine|October 1, 1989
Diagnosis, treatment, and rehabilitation of injuries to the lower leg and footR K Duddy, R J Duggan, H J Visser, et al.
Bioorganic & Medicinal Chemistry|April 7, 2018
Synthesis and evaluation of aminobenzothiazoles as blockers of N- and T-type calcium channelsAnjali Sairaman, Fernanda Caldas Cardoso, Anjie Bispat, et al.
Clinical Radiology|August 13, 2013
Current literature and imaging techniques of aseptic lymphocyte-dominated vasculitis-associated lesions (ALVAL)P J Duggan, C J Burke, S Saha, et al.
Neurogenetics|May 1, 1997
Mutations in the delta-sarcoglycan gene are a rare cause of autosomal recessive limb-girdle muscular dystrophy (LGMD2)D J Duggan, D Manchester, K P Stears, et al.
Irish Journal of Medical Science|September 1, 1986
Chemotherapy treated Hodgkins disease--a fifteen year reviewJ P Bourke, J J Fennelly, J Duggan, et al.
Chemical Communications (Cambridge, England)|December 18, 2007
A new diastereoselective aza-allyl conjugate addition-Michael addition-ring closure reaction sequence and its application in the construction of six contiguous stereogenic centresMagdaline Koutsaplis, Philip C Andrews, Steven D Bull, et al.
Bioorganic & Medicinal Chemistry|November 26, 2009
Carboxymethylated-kappa-casein: a convenient tool for the identification of polyphenolic inhibitors of amyloid fibril formationJohn A Carver, Peter J Duggan, Heath Ecroyd, et al.
Pageof 32

Showing results (171-180 of 316) with videos related to

Sort By:
Pageof 32
Muscle & Nerve|May 19, 1998
Homozygous alpha-sarcoglycan mutation in two siblings: one asymptomatic and one steroid-responsive mild limb-girdle muscular dystrophy patientC Angelini, M Fanin, E Menegazzo, et al.
Neurology|January 28, 1999
The clinical spectrum of sarcoglycanopathiesC Angelini, M Fanin, M P Freda, et al.
Pathology Annual|January 1, 1991
Non-Hodgkin's lymphomas of mantle zone originD D Weisenburger, M J Duggan, D A Perry, et al.
Clinics in Sports Medicine|October 1, 1989
Diagnosis, treatment, and rehabilitation of injuries to the lower leg and footR K Duddy, R J Duggan, H J Visser, et al.
Bioorganic & Medicinal Chemistry|April 7, 2018
Synthesis and evaluation of aminobenzothiazoles as blockers of N- and T-type calcium channelsAnjali Sairaman, Fernanda Caldas Cardoso, Anjie Bispat, et al.
Clinical Radiology|August 13, 2013
Current literature and imaging techniques of aseptic lymphocyte-dominated vasculitis-associated lesions (ALVAL)P J Duggan, C J Burke, S Saha, et al.
Neurogenetics|May 1, 1997
Mutations in the delta-sarcoglycan gene are a rare cause of autosomal recessive limb-girdle muscular dystrophy (LGMD2)D J Duggan, D Manchester, K P Stears, et al.
Irish Journal of Medical Science|September 1, 1986
Chemotherapy treated Hodgkins disease--a fifteen year reviewJ P Bourke, J J Fennelly, J Duggan, et al.
Chemical Communications (Cambridge, England)|December 18, 2007
A new diastereoselective aza-allyl conjugate addition-Michael addition-ring closure reaction sequence and its application in the construction of six contiguous stereogenic centresMagdaline Koutsaplis, Philip C Andrews, Steven D Bull, et al.
Bioorganic & Medicinal Chemistry|November 26, 2009
Carboxymethylated-kappa-casein: a convenient tool for the identification of polyphenolic inhibitors of amyloid fibril formationJohn A Carver, Peter J Duggan, Heath Ecroyd, et al.
Pageof 32